To be or not to be B7

Xingxing Zang, James P. Allison

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The activation of lymphocytes and development of adaptive immune responses is initiated by the engagement of TCRs by antigenic peptide-MHC complexes and shaped at the clonal level by both positive and negative costimulatory signals. The B7 family members are involved at several stages in this process. In this issue of the JCI, Vogt et al. show that the B7 family-related protein V-set and Ig domain-containing 4 (VSIG4) can act as an inhibitor of T cell activation (see the related article beginning on page 2817). Intriguingly, the same molecule was recently independently identified as a complement receptor of the Ig superfamily (CRIg) and was convincingly demonstrated to be a receptor for complement component 3 fragments. These findings raise interesting questions regarding the physiological roles and mechanisms of action of this molecule. Identification of dual functions of this molecule provides an additional level of complexity in T cell costimulation.

Original languageEnglish (US)
Pages (from-to)2590-2593
Number of pages4
JournalJournal of Clinical Investigation
Volume116
Issue number10
DOIs
StatePublished - Oct 2 2006
Externally publishedYes

Fingerprint

T-Lymphocytes
Complement Receptors
Complement C3
Adaptive Immunity
Lymphocyte Activation
Peptides
Proteins
Immunoglobulin Domains

ASJC Scopus subject areas

  • Medicine(all)

Cite this

To be or not to be B7. / Zang, Xingxing; Allison, James P.

In: Journal of Clinical Investigation, Vol. 116, No. 10, 02.10.2006, p. 2590-2593.

Research output: Contribution to journalArticle

Zang, Xingxing ; Allison, James P. / To be or not to be B7. In: Journal of Clinical Investigation. 2006 ; Vol. 116, No. 10. pp. 2590-2593.
@article{94b2139463ae4564ba711adb581a038b,
title = "To be or not to be B7",
abstract = "The activation of lymphocytes and development of adaptive immune responses is initiated by the engagement of TCRs by antigenic peptide-MHC complexes and shaped at the clonal level by both positive and negative costimulatory signals. The B7 family members are involved at several stages in this process. In this issue of the JCI, Vogt et al. show that the B7 family-related protein V-set and Ig domain-containing 4 (VSIG4) can act as an inhibitor of T cell activation (see the related article beginning on page 2817). Intriguingly, the same molecule was recently independently identified as a complement receptor of the Ig superfamily (CRIg) and was convincingly demonstrated to be a receptor for complement component 3 fragments. These findings raise interesting questions regarding the physiological roles and mechanisms of action of this molecule. Identification of dual functions of this molecule provides an additional level of complexity in T cell costimulation.",
author = "Xingxing Zang and Allison, {James P.}",
year = "2006",
month = "10",
day = "2",
doi = "10.1172/JCI30103",
language = "English (US)",
volume = "116",
pages = "2590--2593",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "10",

}

TY - JOUR

T1 - To be or not to be B7

AU - Zang, Xingxing

AU - Allison, James P.

PY - 2006/10/2

Y1 - 2006/10/2

N2 - The activation of lymphocytes and development of adaptive immune responses is initiated by the engagement of TCRs by antigenic peptide-MHC complexes and shaped at the clonal level by both positive and negative costimulatory signals. The B7 family members are involved at several stages in this process. In this issue of the JCI, Vogt et al. show that the B7 family-related protein V-set and Ig domain-containing 4 (VSIG4) can act as an inhibitor of T cell activation (see the related article beginning on page 2817). Intriguingly, the same molecule was recently independently identified as a complement receptor of the Ig superfamily (CRIg) and was convincingly demonstrated to be a receptor for complement component 3 fragments. These findings raise interesting questions regarding the physiological roles and mechanisms of action of this molecule. Identification of dual functions of this molecule provides an additional level of complexity in T cell costimulation.

AB - The activation of lymphocytes and development of adaptive immune responses is initiated by the engagement of TCRs by antigenic peptide-MHC complexes and shaped at the clonal level by both positive and negative costimulatory signals. The B7 family members are involved at several stages in this process. In this issue of the JCI, Vogt et al. show that the B7 family-related protein V-set and Ig domain-containing 4 (VSIG4) can act as an inhibitor of T cell activation (see the related article beginning on page 2817). Intriguingly, the same molecule was recently independently identified as a complement receptor of the Ig superfamily (CRIg) and was convincingly demonstrated to be a receptor for complement component 3 fragments. These findings raise interesting questions regarding the physiological roles and mechanisms of action of this molecule. Identification of dual functions of this molecule provides an additional level of complexity in T cell costimulation.

UR - http://www.scopus.com/inward/record.url?scp=33749443579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749443579&partnerID=8YFLogxK

U2 - 10.1172/JCI30103

DO - 10.1172/JCI30103

M3 - Article

C2 - 17016555

AN - SCOPUS:33749443579

VL - 116

SP - 2590

EP - 2593

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 10

ER -